Drug Target Review
AUGUST 24, 2023
Prior to joining CatalYm, Christine co-founded Rigontec in 2014 where she led the company’s discovery and non-clinical development activities as Senior Vice President, Research. Shear forces induce ICAM-1 nanoclustering on endothelial cells that impact on T-cell migration. Current Opinion in Cell Biology.
PerkinElmer
JANUARY 21, 2022
1 To address the urgent need for new therapies, the UK’s Medical Research Council (MRC), a national public agency supporting health science and research, established the Dementias Platform United Kingdom (DPUK) in 2014. Unless something is done, experts predict these numbers will likely double within the next 20 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
MAY 21, 2024
I don’t think that it’s harder for women to enter careers in STEM, at least not in the scientific field—cell biology—that I have predominantly worked in. She returned to Cardiff in 2014 for a Research Fellowship at the European Cancer Stem Cell Research Institute.
NIH Director's Blog: Drug Discovery
APRIL 11, 2017
2014 Jan 9;8(1):e2628. [2] References : [1] Cofactor-independent phosphoglycerate mutase from nematodes has limited druggability, as revealed by two high-throughput screens. Crowther GJ, Booker ML, He M, Li T, Raverdy S, Novelli JF, He P, Dale NR, Fife AM, Barker RH Jr, Kramer ML, Van Voorhis WC, Carlow CK, Wang MW. PLoS Negl Trop Dis.
Drug Target Review
NOVEMBER 17, 2023
Professor Alan Trounson AO CEO, Executive Director, Cartherics Alan is the past President of the Californian Institute for Regenerative Medicine (2007-2014), the Californian state’s $3 billion stem cell agency driving research in stem cell biology and facilitating the translation of stem cell discoveries into clinical therapies.
Broad Institute
OCTOBER 11, 2023
By Allessandra DiCorato October 11, 2023 In 2011, Robert Manguso was working in a cell biology lab when his mother was diagnosed with Merkel cell carcinoma, a rare and aggressive skin cancer. They are used to treat cancers including melanoma and non-small cell lung cancer, but work only for a small fraction of patients.
Drug Discovery World
OCTOBER 14, 2022
However, despite this long list of features that makes MALDI-TOF MS suitable for drug screening, it was not until 2014 that the first study detailing its use in a high-throughput assay was published. Xia, in Encyclopedia of Toxicology (3rd edition), Elsevier, 2014. References . Attene-Ramos and M. Elsen and J.D. Kelly, N.T.
Expert insights. Personalized for you.
98 
Let's personalize your content